NEW YORK, Nov. 15 (GenomeWeb News) - Pressure BioSciences sold its first bench-top PCT sample-preparation system to the US Food and Drug Administration, the company said today.
The company also signed a one-year lease with the University of New Hampshire and a three-month lease with a midwestern biotech firm for the system.
The FDA is expected to use the system to extract proteins from bacteria, to process food to detect allergen contamination, and to evaluate dietary supplements, Pressure said.
The University of New Hampshire and the biotech company are expected to use the system to process biological samples to study DNA, RNA, and proteins.
Additional details were not disclosed.